by Eric Christianson | Sep 15, 2019 | Clinical Guideline Updates For Pharmacists
The Beers Criteria was updated in 2019. Of the numerous updates, I wanted to pull out my top 5 clinically relevant Beers Criteria updates. It is important to note that there were many more updates, but I wanted to share some of the most clinically important updates....
by Eric Christianson | Sep 11, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Clinical Pharmacy News and New Drug Updates, Medication and Disease State Clinical Pearls For Pharmacists
I’m a little bummed about my Minnesota Twins. Drug problems are everywhere and my team is not exempt. Apparently, hydrochlorothiazide is a drug of abuse in MLB’s drug testing policy. Mike Pineda, one of the Twins pitchers failed a drug test and was found...
by Eric Christianson | Sep 8, 2019 | Educational Case Studies For Pharmacists, Hematology and Immunology Case Studies
The following case on methotrexate and thrombocytopenia was donated by Kirk Seale, M.S., PharmD, BCGP. Kirk received his Master’s degree in Drug regulatory affairs from the University of Florida and received his PharmD from the University of Mississippi. He has also...
by Eric Christianson | Sep 4, 2019 | Educational Case Studies For Pharmacists, Psychiatry and Addiction Medicine Case Studies
A 66-year-old female has a past medical history of diabetes, neuropathy, depression, and hypertension. In this case scenario, I discuss the use of a TCA with an SNRI. Her current medication list includes: Aspirin 81 mg dailyCapsaicin cream prnAmitriptyline 10 mg at...
by Eric Christianson | Sep 1, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Benzodiazepines are on the Beers criteria. They can have significant adverse effects like sedation, confusion, the risk for dependence, and increased fall risk. We like to avoid benzodiazepines if we can, but what if we do feel that it is necessary (i.e. hospice or...
